Psilocybin

Views 3957
Download the GMI DOC on this Topic

Sign in to Purchase/Download Documents

Sign in / Register

Focus Your Research

Click any topic below to filter + focus research
45 Diseases Researched for Psilocybin
NameACCKFocus
Depression69374Locked
Anxiety18112Locked
Mood Disorders752Locked
Depression350Locked
Psychiatric Disorders745Locked
Anxiety: End of Life533Locked
Cancers: All633Locked
Post-Traumatic Stress Disorders (PTSD)525Locked
Alcohol Addiction523Locked
Obsessive-Compulsive Disorder823Locked
Anxiety Disorders422Locked
Cancers: Psychological Stress422Locked
Anorexia312Locked
Dysmorphophobia211Locked
Chronic Pain110Locked
Cluster Headache110Locked
Drug Abuse110Locked
Lyme Disease110Locked
Phantom Limb110Locked
Psychological Distress110Locked
Suicidal Behavior110Locked
Suicidal Ideation110Locked
Inflammation34Locked
Anosmia13Locked
Lupus-Like Syndrome13Locked
Neurosis: Obsessive-Compulsive13Locked
Alzheimer's Disease22Locked
Brain Inflammation 12Locked
Cognitive Decline/Dysfunction12Locked
Fragile X Syndrome12Locked
Lipopolysaccharide-Induced Toxicity12Locked
Obesity12Locked
Psychiatric Disorder: Conditioned Fear12Locked
Substance Abuse22Locked
Tobacco Addiction/Withdrawal22Locked
Aging11Locked
Borderline Personality Disorder11Locked
Depressive Disorder11Locked
Drug Addiction11Locked
Drug Dependence11Locked
Neurodegenerative Diseases11Locked
Neurological Conditions11Locked
Neuropathic Pain11Locked
Smoking Cessation11Locked
Substance Use Disorders11Locked
18 Pharmacological Actions Researched for Psilocybin
NameACCKFocus
Antidepressive Agents70413Locked
Anti-Anxiety Agents25146Locked
Neuroprotective Agents836Locked
Anti-Inflammatory Agents627Locked
Anxiolytic120Locked
Neuromodulatory120Locked
Analgesics314Locked
Interleukin-6 Downregulation313Locked
Immunomodulatory211Locked
Interleukin-1 beta downregulation211Locked
Neuroplasticity enhancement57Locked
Cyclooxygenase 2 Inhibitors23Locked
Neurogenesis23Locked
Tumor Necrosis Factor (TNF) Alpha Inhibitor23Locked
Brain-derived neurotrophic factor modulator22Locked
Prophylactic Agents12Locked
Monoamine Oxidase Inhibitors11Locked
Telomere Protective11Locked

View the Evidence:
147 Abstracts with Psilocybin Research

[+]

A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy.Jun 11, 2020

Pubmed Data : J Psychoactive Drugs. 2020 Jun 12:1-11. Epub 2020 Jun 12. PMID: 32529966
Article Published Date : Jun 11, 2020
Study Type : Meta Analysis
Additional Links
Substances : Ayahuasca, Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Anxiety, Depression, Post-Traumatic Stress Disorders (PTSD)
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Classic serotonergic psychedelics for mood and depressive symptoms.Jan 31, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Psychopharmacology (Berl). 2021 Feb ;238(2):341-354. Epub 2021 Jan 11. PMID: 33427944
Article Published Date : Jan 31, 2021
Study Type : Meta Analysis
Additional Links
Substances : Ayahuasca, Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Dose effect of psilocybin on primary and secondary depression.Sep 16, 2021

Pubmed Data : J Affect Disord. 2021 Sep 17 ;296:26-34. Epub 2021 Sep 17. PMID: 34587546
Article Published Date : Sep 16, 2021
Study Type : Meta Analysis, Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin as a new approach to treat depression and anxiety in the context of life-threatening diseases.Sep 04, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Biomedicines. 2020 Sep 5 ;8(9). Epub 2020 Sep 5. PMID: 32899469
Article Published Date : Sep 04, 2020
Study Type : Meta Analysis, Review
Additional Links
Substances : Psilocybin
Diseases : Anxiety, Anxiety: End of Life, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.Oct 31, 2022

Pubmed Data : Cureus. 2022 Nov ;14(11):e31796. Epub 2022 Nov 22. PMID: 36569662
Article Published Date : Oct 31, 2022
Study Type : Meta Analysis
Additional Links
Substances : Psilocybin
Diseases : Psychiatric Disorders
[+]

Systematic review: psychedelics appear to be effective in significantly reducing symptoms of depression and anxiety and are well-tolerated.Jul 29, 2019

Pubmed Data : J Affect Disord. 2019 Jul 30 ;258:11-24. Epub 2019 Jul 30. PMID: 31382100
Article Published Date : Jul 29, 2019
Study Type : Meta Analysis
Additional Links
Substances : Ayahuasca, Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents, Anxiolytic
[+]

The effects of tryptamine psychedelics in the brain: a meta-analysis of functional and review of molecular imaging studies.Dec 31, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Pharmacol. 2021 ;12:739053. Epub 2021 Sep 29. PMID: 34658876
Article Published Date : Dec 31, 2020
Study Type : Meta Analysis, Review
Additional Links
Substances : Psilocybin
Pharmacological Actions : Neuromodulatory
[+]

The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.Jan 01, 2020

Pubmed Data : Psychiatry Res. 2020 Jan 2 ;284:112749. Epub 2020 Jan 2. PMID: 31931272
Article Published Date : Jan 01, 2020
Study Type : Meta Analysis
Additional Links
Substances : Psilocybin
Diseases : Anxiety, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

A single administration of psilocybin may be associated with sub-acute enhancement of creative thinking, empathy, and subjective well-being.Feb 25, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Psychoactive Drugs. 2019 Feb 26:1-12. Epub 2019 Feb 26. PMID: 30905276
Article Published Date : Feb 25, 2019
Study Type : Human Study
Additional Links
Substances : Psilocybin
[+]

A single dose psilocybin produced rapid and enduring anxiolytic and anti-depressant effects in patients with cancer-related psychological distress.Nov 30, 2016

Pubmed Data : J Psychopharmacol. 2016 Dec ;30(12):1165-1180. PMID: 27909164
Article Published Date : Nov 30, 2016
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Cancers: All, Depression
Pharmacological Actions : Antidepressive Agents
[+]

A single psilocybin dose is associated with long-term increased mindfulness.Mar 03, 2020

Pubmed Data : Eur Neuropsychopharmacol. 2020 Mar 4. Epub 2020 Mar 4. PMID: 32146028
Article Published Date : Mar 03, 2020
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Mood Disorders
[+]

Decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees.Dec 31, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Psychiatry. 2022 ;13:883869. Epub 2022 Jul 7. PMID: 35873251
Article Published Date : Dec 31, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Anxiety
Pharmacological Actions : Anti-Anxiety Agents
[+]

Effects of psilocybin therapy on personality structure.Oct 31, 2018

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Acta Psychiatr Scand. 2018 Nov ;138(5):368-378. Epub 2018 Jun 19. PMID: 29923178
Article Published Date : Oct 31, 2018
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
Additional Keywords : Natural Substances Versus Drugs
[+]

Exploring the use of psilocybin therapy for existential distress.Jul 15, 2021

Pubmed Data : J Psychoactive Drugs. 2021 Jul 16:1-12. Epub 2021 Jul 16. PMID: 34266372
Article Published Date : Jul 15, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Psychological Distress
[+]

High dose psilocybin is associated with positive subjective effects in healthy volunteers.May 31, 2018

Pubmed Data : J Psychopharmacol. 2018 Jun 1:269881118780713. Epub 2018 Jun 1. PMID: 29945469
Article Published Date : May 31, 2018
Study Type : Human Study
Additional Links
Substances : Psilocybin
[+]

Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Jun 29, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Psychopharmacol. 2021 Jun 30:2698811211026454. Epub 2021 Jun 30. PMID: 34189985
Article Published Date : Jun 29, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
[+]

Lifetime psilocybin use was associated with lowered odds of lifetime suicidal thinking, planning, and attempts.Dec 18, 2022

Pubmed Data : Sci Rep. 2022 Dec 19 ;12(1):21927. Epub 2022 Dec 19. PMID: 36535992
Article Published Date : Dec 18, 2022
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Suicidal Behavior, Suicidal Ideation
[+]

Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.Dec 31, 2021

Pubmed Data : J Psychopharmacol. 2022 01 ;36(1):57-65. Epub 2022 Jan 5. PMID: 34983261
Article Published Date : Dec 31, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
Additional Keywords : Risk Reduction
[+]

Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.Oct 05, 2021

Pubmed Data : Psychopharmacology (Berl). 2021 Oct 6. Epub 2021 Oct 6. PMID: 34613430
Article Published Date : Oct 05, 2021
Study Type : Human Study
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
[+]

Microdosing psilocybin for chronic pain: a case series.Sep 04, 2022

Pubmed Data : Pain. 2022 Sep 5. Epub 2022 Sep 5. PMID: 36066961
Article Published Date : Sep 04, 2022
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Chronic Pain
Pharmacological Actions : Analgesics
[+]

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.Jan 31, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Psychopharmacology (Berl). 2019 Feb ;236(2):731-740. Epub 2019 Jan 2. PMID: 30604183
Article Published Date : Jan 31, 2019
Study Type : Human Study
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Mood Disorders
[+]

Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.Dec 31, 2017

Pubmed Data : J Affect Disord. 2018 04 1 ;230:84-86. PMID: 29407543
Article Published Date : Dec 31, 2017
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing.Dec 31, 2022

Pubmed Data : Front Psychiatry. 2023 ;14:1199642. Epub 2023 Sep 19. PMID: 37795509
Article Published Date : Dec 31, 2022
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Anxiety, Depression, Mood Disorders
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.May 22, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Neuroimage. 2020 May 23:116980. Epub 2020 May 23. PMID: 32454209
Article Published Date : May 22, 2020
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Psychiatric Disorders
Pharmacological Actions : Neuroprotective Agents
[+]

Psilocybin and LSD led to beneficial responses in cluster headaches.Jun 26, 2006

Pubmed Data : Neurology. 2006 Jun 27 ;66(12):1920-2. PMID: 16801660
Article Published Date : Jun 26, 2006
Study Type : Human Study
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Cluster Headache
Additional Keywords : Significant Treatment Outcome
[+]

Psilocybin could prove to be revolutionary in treating depression and become an alternative medication to SSRIs.Feb 28, 2024

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Clin Psychopharmacol Neurosci. 2024 Feb 29 ;22(1):2-12. Epub 2023 Oct 16. PMID: 38247407
Article Published Date : Feb 28, 2024
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.Aug 31, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Neuropsychopharmacology. 2023 Sep ;48(10):1492-1499. Epub 2023 Jul 13. PMID: 37443386
Article Published Date : Aug 31, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin has distinct effects on social cognition by enhancing emotional empathy.Aug 31, 2017

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Int J Neuropsychopharmacol. 2017 Sep 1 ;20(9):747-757. PMID: 28637246
Article Published Date : Aug 31, 2017
Study Type : Human Study
Additional Links
Substances : Psilocybin
[+]

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers.Oct 31, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Brain Behav Immun. 2023 Nov ;114:299-310. Epub 2023 Sep 7. PMID: 37689275
Article Published Date : Oct 31, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Anti-Inflammatory Agents, Immunomodulatory, Interleukin-1 beta downregulation, Interleukin-6 Downregulation
[+]

Psilocybin induces time-dependent changes in global functional connectivity.Jan 12, 2020

Pubmed Data : Biol Psychiatry. 2020 Jan 13. Epub 2020 Jan 13. PMID: 32111343
Article Published Date : Jan 12, 2020
Study Type : Human Study
Additional Links
Substances : Psilocybin
[+]

Psilocybin may provide an alternative model for the treatment of anxiety and despair that often accompany advanced-stage cancers.Dec 31, 2010

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Arch Gen Psychiatry. 2011 Jan ;68(1):71-8. Epub 2010 Sep 6. PMID: 20819978
Article Published Date : Dec 31, 2010
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Anxiety Disorders, Cancers: Psychological Stress
Pharmacological Actions : Anti-Anxiety Agents
[+]

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Jun 29, 2022

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Sci Rep. 2022 Jun 30 ;12(1):11091. Epub 2022 Jun 30. PMID: 35773270
Article Published Date : Jun 29, 2022
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Anxiety, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
Additional Keywords : Low-Dose Pharmacology
[+]

Psilocybin modulated effective connectivity within the visual-limbic-prefrontal network during threat processing.Dec 31, 2015

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Neuroimage Clin. 2016 ;11:53-60. Epub 2015 Aug 22. PMID: 26909323
Article Published Date : Dec 31, 2015
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Anxiety Disorders, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer.Nov 30, 2016

Pubmed Data : J Psychopharmacol. 2016 Dec ;30(12):1181-1197. PMID: 27909165
Article Published Date : Nov 30, 2016
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Cancers: All, Depression
Pharmacological Actions : Antidepressive Agents
Additional Keywords : Significant Treatment Outcome
[+]

Psilocybin represents a promising paradigm for unresponsive depression.Nov 07, 2017

Pubmed Data : Psychopharmacology (Berl). 2017 Nov 8. Epub 2017 Nov 8. PMID: 29119217
Article Published Date : Nov 07, 2017
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study.Jul 31, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Nat Med. 2023 Aug ;29(8):1947-1953. Epub 2023 Jul 24. PMID: 37488291
Article Published Date : Jul 31, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Anorexia
[+]

Psilocybin therapy for treatment resistant depression.Aug 21, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Psychopharmacology (Berl). 2023 Aug 22. Epub 2023 Aug 22. PMID: 37606733
Article Published Date : Aug 21, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Nov 07, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Transl Psychiatry. 2021 Nov 8 ;11(1):574. Epub 2021 Nov 8. PMID: 34750350
Article Published Date : Nov 07, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin treatment led to significant decreases in alcohol craving and increased the abstinence from alcohol. Feb 28, 2015

Pubmed Data : J Psychopharmacol. 2015 Mar ;29(3):289-99. Epub 2015 Jan 13. PMID: 25586396
Article Published Date : Feb 28, 2015
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Alcohol Addiction
Additional Keywords : Significant Treatment Outcome
[+]

Psilocybin treatment was associated with a clinically significant sustained reduction in depressive symptoms and functional disability.Sep 04, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : JAMA. 2023 Sep 5 ;330(9):843-853. PMID: 37651119
Article Published Date : Sep 04, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin with psychological support is a treatment approach that potentially revives emotional responsiveness in depression.Dec 26, 2017

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Neuropharmacology. 2017 Dec 27. Epub 2017 Dec 27. PMID: 29288686
Article Published Date : Dec 26, 2017
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin-assisted group therapy and attachment: observed reduction in attachment anxiety.Apr 08, 2021

Pubmed Data : ACS Pharmacol Transl Sci. 2021 Apr 9 ;4(2):526-532. Epub 2020 Dec 9. PMID: 33860182
Article Published Date : Apr 08, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Anxiety
Pharmacological Actions : Anti-Anxiety Agents
[+]

Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Mar 31, 2024

Pubmed Data : Cancer. 2024 Apr 1 ;130(7):1137-1146. Epub 2023 Dec 18. PMID: 38105655
Article Published Date : Mar 31, 2024
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Cancers: All, Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects.Apr 05, 2019

Pubmed Data : Neuroimage. 2019 Apr 6 ;196:207-215. Epub 2019 Apr 6. PMID: 30965131
Article Published Date : Apr 05, 2019
Study Type : Human Study
Additional Links
Substances : Psilocybin
Therapeutic Actions : Meditation , Mindfullness Training
[+]

Psilocybin-assisted psychotherapy for treatment resistant depression.Mar 07, 2024

Pubmed Data : Med. 2024 Mar 8 ;5(3):190-200.e5. Epub 2024 Feb 14. PMID: 38359838
Article Published Date : Mar 07, 2024
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin-assisted therapy for major depressive disorder.Mar 19, 2023

Pubmed Data : J Psychopharmacol. 2023 Mar 20:2698811231154852. Epub 2023 Mar 20. PMID: 36938991
Article Published Date : Mar 19, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.Jul 07, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Eur Neuropsychopharmacol. 2021 Jul 8 ;50:121-132. Epub 2021 Jul 8. PMID: 34246868
Article Published Date : Jul 07, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
Additional Keywords : Altered States Of Consciousness
[+]

Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Dec 31, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Pharmacol. 2022 ;13:841648. Epub 2022 Mar 9. PMID: 35355714
Article Published Date : Dec 31, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
[+]

Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Dec 31, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Pharmacol. 2022 ;13:841648. Epub 2022 Mar 9. PMID: 35355714
Article Published Date : Dec 31, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
[+]

Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.Jul 31, 2015

Pubmed Data : Psychopharmacology (Berl). 2015 Aug 1. Epub 2015 Aug 1. PMID: 26231498
Article Published Date : Jul 31, 2015
Study Type : Human Study
Additional Links
Substances : Psilocybin
Therapeutic Actions : Spiritual Beliefs
Additional Keywords : Spiritual Experiences
[+]

Psilocybin-occasioned mystical-type experience in combination with meditation and spiritual practices produces enduring positive changes.Aug 31, 2017

Pubmed Data : J Psychopharmacol. 2017 Sep 1:269881117731279. Epub 2017 Sep 1. PMID: 29020861
Article Published Date : Aug 31, 2017
Study Type : Human Study
Additional Links
Substances : Psilocybin
Therapeutic Actions : Meditation , Spiritual Beliefs
Additional Keywords : Spiritual Experiences
[+]

Psychedelic microdosing benefits and challenges: an empirical codebook.Jul 09, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Harm Reduct J. 2019 Jul 10 ;16(1):43. Epub 2019 Jul 10. PMID: 31288862
Article Published Date : Jul 09, 2019
Study Type : Human Study
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Mood Disorders
Additional Keywords : Low-Dose Pharmacology
[+]

Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback Mar 31, 2018

Pubmed Data : Neurocase. 2018 Apr ;24(2):105-110. Epub 2018 May 15. PMID: 29764303
Article Published Date : Mar 31, 2018
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Phantom Limb
[+]

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.Oct 31, 2006

Pubmed Data : J Clin Psychiatry. 2006 Nov ;67(11):1735-40. PMID: 17196053
Article Published Date : Oct 31, 2006
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Obsessive-Compulsive Disorder
[+]

Single-dose psilocybin for a treatment-resistant episode of major depression.Apr 13, 2023

Pubmed Data : J Affect Disord. 2023 Apr 14 ;327:120-127. Epub 2023 Feb 4. PMID: 36740140
Article Published Date : Apr 13, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Single-dose psilocybin-assisted therapy in major depressive disorderJan 31, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : EClinicalMedicine. 2023 Feb ;56:101809. Epub 2022 Dec 28. PMID: 36636296
Article Published Date : Jan 31, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

The effectiveness of microdosed psilocybin in the treatment of neuropsychiatric lyme disease.Dec 31, 2022

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Int Med Case Rep J. 2023 ;16:109-115. Epub 2023 Mar 3. PMID: 36896410
Article Published Date : Dec 31, 2022
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Lyme Disease
Pharmacological Actions : Anti-Inflammatory Agents, Neuroprotective Agents
[+]

These findings suggest that psilocybin-assisted psychotherapy holds promise in promoting long-term relief from cancer-related psychiatric distress.Jan 31, 2020

Pubmed Data : J Psychopharmacol. 2020 Feb ;34(2):155-166. Epub 2020 Jan 9. PMID: 31916890
Article Published Date : Jan 31, 2020
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Anxiety: End of Life, Cancers: Psychological Stress
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

These results are consistent with the idea that psilocybin therapy revives emotional responsiveness on a neural and psychological level.Jan 31, 2020

Pubmed Data : J Psychopharmacol. 2020 Feb ;34(2):167-180. Epub 2020 Jan 16. PMID: 31941394
Article Published Date : Jan 31, 2020
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Neuroprotective Agents
[+]

These results suggest that hallucinogens may promote alcohol and other drug abstinence and prosocial behavior in a population with high rates of recidivism.Dec 31, 2013

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Psychopharmacol. 2014 Jan ;28(1):62-6. PMID: 24399338
Article Published Date : Dec 31, 2013
Study Type : Human Study
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Alcohol Addiction, Drug Abuse
[+]

This pilot study suggests that psilocybin with psychological support might produce lasting changes in attitudes and beliefs. Dec 31, 2017

Pubmed Data : J Psychopharmacol. 2018 Jan 1:269881117748902. Epub 2018 Jan 1. PMID: 29338538
Article Published Date : Dec 31, 2017
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
Additional Keywords : Antidepressive Agents, Depression, Psilocybin
[+]

This study found no significant associations between lifetime use of any psychedelics in the past year of use and increased rate of mental health outcomes.Dec 31, 2012

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : PLoS One. 2013 ;8(8):e63972. Epub 2013 Aug 19. PMID: 23976938
Article Published Date : Dec 31, 2012
Study Type : Human Study
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Psychiatric Disorders
Additional Keywords : Risk Reduction
[+]

This study provides preliminary support for the safety and efficacy of psilocybin for treatment-resistant depression.Jun 30, 2016

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Lancet Psychiatry. 2016 Jul ;3(7):619-27. Epub 2016 May 17. PMID: 27210031
Article Published Date : Jun 30, 2016
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

This study provides promising preliminary support for psilocybin as a treatment of body dysmorphic disorder.Apr 30, 2023

Pubmed Data : J Psychiatr Res. 2023 May ;161:364-370. Epub 2023 Mar 28. PMID: 37004409
Article Published Date : Apr 30, 2023
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Dysmorphophobia
[+]

Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings.Jan 20, 2020

Pubmed Data : Proc Natl Acad Sci U S A. 2020 Jan 21. Epub 2020 Jan 21. PMID: 31964815
Article Published Date : Jan 20, 2020
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Mood Disorders
[+]

Treatment with psilocybin decreased amygdala reactivity during emotion processing and that this was associated with an increase of positive mood in healthy volunteers.Oct 14, 2015

Pubmed Data : Biol Psychiatry. 2015 Oct 15 ;78(8):572-81. Epub 2014 Apr 26. PMID: 24882567
Article Published Date : Oct 14, 2015
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Trial of psilocybin versus escitalopram for depression. Jan 14, 2021

Pubmed Data : N Engl J Med. 2021 04 15 ;384(15):1402-1411. PMID: 33852780
Article Published Date : Jan 14, 2021
Study Type : Human Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
Additional Keywords : Natural Substances Versus Drugs
[+]

In this case report an individual successfully used psilocybin to reduce the core symptoms of OCD for several years.Oct 31, 2014

Pubmed Data : J Psychoactive Drugs. 2014 Nov-Dec;46(5):393-5. PMID: 25364991
Article Published Date : Oct 31, 2014
Study Type : Human: Case Report
Additional Links
Substances : Psilocybin
Diseases : Obsessive-Compulsive Disorder
[+]

Long-term amelioration of OCD symptoms in a patient with chronic consumption of psilocybin-containing mushrooms.Mar 31, 2021

Pubmed Data : J Psychoactive Drugs. 2021 Apr-Jun;53(2):146-148. Epub 2020 Nov 22. PMID: 33225874
Article Published Date : Mar 31, 2021
Study Type : Human: Case Report
Additional Links
Substances : Psilocybin
Diseases : Obsessive-Compulsive Disorder
Additional Keywords : Significant Treatment Outcome
[+]

Potential benefits of psilocybin for lupus pain.Sep 03, 2023

Pubmed Data : Curr Rheumatol Rev. 2023 Sep 4. Epub 2023 Sep 4. PMID: 37670693
Article Published Date : Sep 03, 2023
Study Type : Human: Case Report
Additional Links
Substances : Psilocybin
Diseases : Lupus-Like Syndrome
Pharmacological Actions : Analgesics
[+]

Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.Nov 30, 2022

Pubmed Data : Heliyon. 2022 Dec ;8(12):e12135. Epub 2022 Dec 6. PMID: 36536916
Article Published Date : Nov 30, 2022
Study Type : Human: Case Report
Additional Links
Substances : Psilocybin
Diseases : Neurosis: Obsessive-Compulsive, Obsessive-Compulsive Disorder
[+]

Three cases of reported improvement in microsmia and anosmia following naturalistic use of psilocybin and LSD.Aug 30, 2023

Pubmed Data : J Psychoactive Drugs. 2023 Aug 31:1-8. Epub 2023 Aug 31. PMID: 37650700
Article Published Date : Aug 30, 2023
Study Type : Human: Case Report
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Anosmia
Pharmacological Actions : Anti-Inflammatory Agents
[+]

Acute psilocybin enhances cognitive flexibility in rats.May 31, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Neuropsychopharmacology. 2023 Jun ;48(7):1011-1020. Epub 2023 Feb 20. PMID: 36807609
Article Published Date : May 31, 2023
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Anxiety, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.Apr 26, 2021

Pubmed Data : Proc Natl Acad Sci U S A. 2021 Apr 27 ;118(17). PMID: 33850049
Article Published Date : Apr 26, 2021
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Low doses of psilocybin and ketamine enhance motivation and attention in poor performing rats: evidence for an antidepressant property.Dec 31, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Pharmacol. 2021 ;12:640241. Epub 2021 Feb 26. PMID: 33716753
Article Published Date : Dec 31, 2020
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin demonstrated modest but significant effects on weight gain.Dec 31, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Psychiatry. 2022 ;13:891512. Epub 2022 May 18. PMID: 35664477
Article Published Date : Dec 31, 2021
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Obesity
Additional Keywords : Anti-Obesity Agents
Anti Therapeutic Actions : Western Diet
[+]

Psilocybin facilitates extinction of the classically conditioned fear response in mice. Jul 31, 2013

Pubmed Data : Exp Brain Res. 2013 Aug ;228(4):481-91. Epub 2013 Jun 2. PMID: 23727882
Article Published Date : Jul 31, 2013
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Post-Traumatic Stress Disorders (PTSD)
Pharmacological Actions : Neurogenesis
Additional Keywords : Extinction Of Fear Conditioning
[+]

Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity Mar 29, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Chin Med J (Engl). 2023 Mar 30. Epub 2023 Mar 30. PMID: 37000971
Article Published Date : Mar 29, 2023
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Psychiatric Disorder: Conditioned Fear
Pharmacological Actions : Neuroplasticity enhancement
[+]

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.Jun 24, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Neuron. 2021 Jun 25. Epub 2021 Jun 25. PMID: 34228959
Article Published Date : Jun 24, 2021
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Pharmacological Actions : Neuroplasticity enhancement
[+]

Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.Dec 31, 2022

Pubmed Data : Psychopharmacology (Berl). 2023 Jan ;240(1):137-147. Epub 2022 Dec 5. PMID: 36469097
Article Published Date : Dec 31, 2022
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Cognitive Decline/Dysfunction, Fragile X Syndrome
Pharmacological Actions : Neuroprotective Agents
[+]

Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections.Oct 01, 2023

Pubmed Data : Mol Psychiatry. 2023 Oct 2. Epub 2023 Oct 2. PMID: 37783788
Article Published Date : Oct 01, 2023
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Psychiatric Disorders
Pharmacological Actions : Prophylactic Agents
[+]

The efect of combined treatment of psilocybin and eugenol on lipopolysaccharide-induced brain inflammation.Mar 13, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Molecules. 2023 Mar 14 ;28(6). Epub 2023 Mar 14. PMID: 36985596
Article Published Date : Mar 13, 2023
Study Type : Animal Study
Additional Links
Substances : Eugenol, Psilocybin
Diseases : Brain Inflammation , Inflammation, Lipopolysaccharide-Induced Toxicity
Pharmacological Actions : Anti-Inflammatory Agents, Cyclooxygenase 2 Inhibitors, Interleukin-6 Downregulation, Tumor Necrosis Factor (TNF) Alpha Inhibitor
[+]

Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Jul 03, 2024

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Psychopharmacology (Berl). 2024 Jul 4. Epub 2024 Jul 4. PMID: 38963553
Article Published Date : Jul 03, 2024
Study Type : Animal Study
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psychedelics in Psychiatry: Neuroplastic, immunomodulatory, and neurotransmitter mechanisms.Dec 31, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Pharmacol Rev. 2021 01 ;73(1):202-277. PMID: 33328244
Article Published Date : Dec 31, 2020
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Psychiatric Disorders
Pharmacological Actions : Immunomodulatory, Neuroplasticity enhancement
[+]

A review of psilocybin as an assisted therapy for psychiatric disorders.May 07, 2017

Pubmed Data : J Psychoactive Drugs. 2017 May 8:1-10. Epub 2017 May 8. PMID: 28481178
Article Published Date : May 07, 2017
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Anxiety, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

A review of psilocybin for trauma-related disorders.Jun 16, 2022

Pubmed Data : Curr Top Behav Neurosci. 2022 Jun 17. Epub 2022 Jun 17. PMID: 35711024
Article Published Date : Jun 16, 2022
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Post-Traumatic Stress Disorders (PTSD)
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

A review of the potential therapeutic effects of psilocybin.Jun 04, 2017

Pubmed Data : Neurotherapeutics. 2017 Jun 5. Epub 2017 Jun 5. PMID: 28585222
Article Published Date : Jun 04, 2017
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Alcohol Addiction, Anxiety, Cancers: Psychological Stress, Depression, Tobacco Addiction/Withdrawal
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.Jul 31, 2022

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Psychopharmacol. 2022 Aug ;36(8):932-942. PMID: 35924888
Article Published Date : Jul 31, 2022
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Awe is the putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.Sep 26, 2018

Pubmed Data : Int Rev Psychiatry. 2018 Sep 27:1-12. Epub 2018 Sep 27. PMID: 30260256
Article Published Date : Sep 26, 2018
Study Type : Commentary
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Psychiatric Disorders
Therapeutic Actions : The Experience of Awe
[+]

Ayahuasca, psilocybin and LSD may be useful tools for the treatment of drug dependence, and anxiety and mood disorders.May 31, 2016

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Ther Adv Psychopharmacol. 2016 Jun ;6(3):193-213. Epub 2016 Mar 18. PMID: 27354908
Article Published Date : May 31, 2016
Study Type : Review
Additional Links
Substances : Ayahuasca, Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Anxiety Disorders, Depression, Drug Dependence
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Classic psychedelics in addiction treatment: the case for psilocybin in tobacco smoking cessation.Dec 31, 2021

Pubmed Data : Curr Top Behav Neurosci. 2022 ;56:213-227. PMID: 35704271
Article Published Date : Dec 31, 2021
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Smoking Cessation
[+]

Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.Jul 26, 2021

Pubmed Data : Int J Drug Policy. 2021 Jul 27 ;98:103380. Epub 2021 Jul 27. PMID: 34329952
Article Published Date : Jul 26, 2021
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Substance Use Disorders
[+]

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.Apr 30, 2019

Pubmed Data : Pharmacol Ther. 2019 May ;197:83-102. Epub 2018 Dec 4. PMID: 30521880
Article Published Date : Apr 30, 2019
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Alcohol Addiction, Anxiety: End of Life, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
Additional Keywords : Spiritual Experiences
[+]

Classical hallucinogens alter the functioning of the serotonergic system which has long been implicated in anxiety and depressive disorders.Jul 31, 2014

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Ther Adv Psychopharmacol. 2014 Aug ;4(4):156-69. PMID: 25083275
Article Published Date : Jul 31, 2014
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Anxiety Disorders, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Depression, mindfulness, and psilocybin: possible complementary effects of mindfulness meditation and psilocybin in the treatment of depression.Dec 31, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Psychiatry. 2020 ;11:224. Epub 2020 Mar 31. PMID: 32296353
Article Published Date : Dec 31, 2019
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Therapeutic Actions : Mindfullness Training
Pharmacological Actions : Antidepressive Agents
[+]

Efficacy and safety of psychedelics for the treatment of mental disorders.Apr 30, 2024

Pubmed Data : Psychiatry Res. 2024 May ;335:115886. Epub 2024 Mar 28. PMID: 38574699
Article Published Date : Apr 30, 2024
Study Type : Review
Additional Links
Substances : Ayahuasca, Psilocybin, Psychedelics:All
Diseases : Anxiety, Borderline Personality Disorder, Depression, Dysmorphophobia, Obsessive-Compulsive Disorder
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Efficacy of psychedelics in psychiatry, a systematic review of the literature.Apr 18, 2021

Pubmed Data : Encephale. 2021 Apr 19. Epub 2021 Apr 19. PMID: 33888297
Article Published Date : Apr 18, 2021
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.Nov 28, 2019

Pubmed Data : Psychopharmacology (Berl). 2019 Nov 29. Epub 2019 Nov 29. PMID: 31784805
Article Published Date : Nov 28, 2019
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Anxiety: End of Life
Pharmacological Actions : Anti-Anxiety Agents
[+]

Esketamine and psilocybin-the comparison of two mind-altering agents in depression treatment.Sep 27, 2022

Pubmed Data : Int J Mol Sci. 2022 Sep 28 ;23(19). Epub 2022 Sep 28. PMID: 36232748
Article Published Date : Sep 27, 2022
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Experience of music used with psychedelic therapy: a rapid review and implications.Mar 29, 2020

Pubmed Data : J Music Ther. 2020 Mar 30. Epub 2020 Mar 30. PMID: 32227084
Article Published Date : Mar 29, 2020
Study Type : Review
Additional Links
Substances : Ayahuasca, Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Therapeutic Actions : Music
[+]

Hallucinogens increase introspection and positive mood by modulating brain activity in the fronto-temporo-parieto-occipital cortex.Nov 30, 2016

Pubmed Data : Neurosci Biobehav Rev. 2016 Dec ;71:715-728. Epub 2016 Oct 31. PMID: 27810345
Article Published Date : Nov 30, 2016
Study Type : Review
Additional Links
Substances : Ayahuasca, Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

LSD and psilocybin may be beneficial for depression and anxiety associated with distress in life-threatening diseases.May 02, 2018

Pubmed Data : Pain Manag. 2018 May 3. Epub 2018 May 3. PMID: 29722608
Article Published Date : May 02, 2018
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Anxiety, Cancers: All, Depression
[+]

Lysergic acid diethylamide, psilocybin and dimethyltryptamine in depression treatment.Aug 11, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Pharmaceuticals (Basel). 2021 Aug 12 ;14(8). Epub 2021 Aug 12. PMID: 34451890
Article Published Date : Aug 11, 2021
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Novel antidepressant drugs: Beyond monoamine targets.Sep 29, 2021

Pubmed Data : CNS Spectr. 2021 Sep 30:1-10. Epub 2021 Sep 30. PMID: 34588093
Article Published Date : Sep 29, 2021
Study Type : Review
Additional Links
Substances : Ayahuasca, Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Opinion: Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.Dec 18, 2022

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Bioeth Inq. 2022 Dec 19:1-9. Epub 2022 Dec 19. PMID: 36534233
Article Published Date : Dec 18, 2022
Study Type : Commentary
Additional Links
Substances : Psilocybin
Diseases : Anorexia
[+]

Pharmacotherapies for treatment-resistant depression.Feb 28, 2023

Pubmed Data : Am J Psychiatry. 2023 Mar 1 ;180(3):190-199. PMID: 36855876
Article Published Date : Feb 28, 2023
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.Jun 14, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Neuropharmacology. 2023 Jun 15 ;231:109504. Epub 2023 Mar 13. PMID: 36921889
Article Published Date : Jun 14, 2023
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression, Inflammation, Psychiatric Disorders
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin and MDMA for the treatment of trauma-related psychopathology.Apr 30, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Int Rev Psychiatry. 2021 May ;33(3):229-249. Epub 2021 Jun 14. PMID: 34121583
Article Published Date : Apr 30, 2021
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depressive Disorder, Post-Traumatic Stress Disorders (PTSD)
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin appears as a valuable treatment for OCD.Jul 31, 2024

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Pharmacol Rep. 2024 Aug 1. Epub 2024 Aug 1. PMID: 39088105
Article Published Date : Jul 31, 2024
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Obsessive-Compulsive Disorder
[+]

Psilocybin efficacy and mechanisms of action in major depressive disorder.Aug 11, 2022

Pubmed Data : Curr Psychiatry Rep. 2022 Aug 12. Epub 2022 Aug 12. PMID: 35953638
Article Published Date : Aug 11, 2022
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin for the treatment of Alzheimer's disease.Dec 31, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Neurosci. 2024 ;18:1420601. Epub 2024 Jul 10. PMID: 39050672
Article Published Date : Dec 31, 2023
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Alzheimer's Disease
Pharmacological Actions : Anti-Inflammatory Agents, Neuroprotective Agents
[+]

Psilocybin for the treatment of depression: a promising new pharmacotherapy approach.Nov 22, 2021

Pubmed Data : Curr Top Behav Neurosci. 2021 Nov 23. Epub 2021 Nov 23. PMID: 34811715
Article Published Date : Nov 22, 2021
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin for the treatment of obsessive-compulsive disorders. Nov 16, 2021

Pubmed Data : Curr Top Behav Neurosci. 2021 Nov 17. Epub 2021 Nov 17. PMID: 34784024
Article Published Date : Nov 16, 2021
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Obsessive-Compulsive Disorder
[+]

Psilocybin may prove to be a safe, feasible, and efficacious pharmacological agent for depression.Dec 31, 2016

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Ther Adv Psychopharmacol. 2017 Jan ;7(1):54-56. Epub 2016 Oct 27. PMID: 28101325
Article Published Date : Dec 31, 2016
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin-assisted psychotherapy for depression.Mar 14, 2022

Pubmed Data : J Neurol Sci. 2022 Mar 15 ;434:120096. Epub 2021 Dec 16. PMID: 34942586
Article Published Date : Mar 14, 2022
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?Aug 16, 2023

Pubmed Data : Int J Ment Health Nurs. 2023 Aug 17. Epub 2023 Aug 17. PMID: 37589380
Article Published Date : Aug 16, 2023
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin-assisted rreatment of depression, anxiety and substance use disorders.May 18, 2023

Pubmed Data : Fortschr Neurol Psychiatr. 2023 May 19. Epub 2023 May 19. PMID: 37207669
Article Published Date : May 18, 2023
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Anxiety, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Psilocybin-assisted therapy for depression.Aug 06, 2023

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Eur Neuropsychopharmacol. 2023 Aug 7 ;76:61-76. Epub 2023 Aug 7. PMID: 37557019
Article Published Date : Aug 06, 2023
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psilocybin: from ancient magic to modern medicine. May 11, 2020

Pubmed Data : J Antibiot (Tokyo). 2020 May 12. Epub 2020 May 12. PMID: 32398764
Article Published Date : May 11, 2020
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Anxiety, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

Psychedelic medicines in major depression: progress and future challenges.Dec 31, 2020

Pubmed Data : Adv Exp Med Biol. 2021 ;1305:515-533. PMID: 33834416
Article Published Date : Dec 31, 2020
Study Type : Review
Additional Links
Substances : Ayahuasca, Psilocybin, Psychedelics:All
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Psychedelic treatment of functional neurological disorder: a systematic reviewDec 31, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Ther Adv Psychopharmacol. 2020 ;10:2045125320912125. Epub 2020 May 11. PMID: 32435447
Article Published Date : Dec 31, 2019
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Neurological Conditions
Pharmacological Actions : Neuroprotective Agents
[+]

Psychedelic-inspired approaches for treating neurodegenerative disorders.Nov 23, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Neurochem. 2021 Nov 24. Epub 2021 Nov 24. PMID: 34816433
Article Published Date : Nov 23, 2021
Study Type : Review
Additional Links
Substances : Ayahuasca, Psilocybin, Psychedelics:All
Diseases : Alzheimer's Disease, Neurodegenerative Diseases
Pharmacological Actions : Neuroplasticity enhancement, Neuroprotective Agents
[+]

Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics.Dec 31, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Psychiatry. 2021 ;12:724606. Epub 2021 Sep 10. PMID: 34566723
Article Published Date : Dec 31, 2020
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Anxiety, Depression
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents, Brain-derived neurotrophic factor modulator, Neuroplasticity enhancement
[+]

Psychedelics could be effective in the treatment of mood, anxiety, and substance use disorders.Jun 03, 2018

Pubmed Data : ACS Chem Neurosci. 2018 Jun 4. Epub 2018 Jun 4. PMID: 29863323
Article Published Date : Jun 03, 2018
Study Type : Review
Additional Links
Substances : Ayahuasca, Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Anxiety, Mood Disorders, Substance Abuse
Pharmacological Actions : Anti-Anxiety Agents
[+]

Psychedelics for Alzheimer's disease-related dementia: unveiling therapeutic possibilities and pathways.Jan 30, 2024

Pubmed Data : Ageing Res Rev. 2024 Jan 31:102211. Epub 2024 Jan 31. PMID: 38307424
Article Published Date : Jan 30, 2024
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Pharmacological Actions : Brain-derived neurotrophic factor modulator, Neuroprotective Agents
[+]

Psychedelics in the treatment of PTSD.Dec 31, 2019

Pubmed Data : Tijdschr Psychiatr. 2020 ;62(8):640-649. PMID: 32816292
Article Published Date : Dec 31, 2019
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Post-Traumatic Stress Disorders (PTSD)
[+]

Psychedelics, sociality, and human evolution. Dec 31, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Psychol. 2021 ;12:729425. Epub 2021 Sep 29. PMID: 34659037
Article Published Date : Dec 31, 2020
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Additional Keywords : Evolutionary Connection
[+]

Rediscovering psilocybin as an antidepressive treatment strategy. Sep 27, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Pharmaceuticals (Basel). 2021 Sep 28 ;14(10). Epub 2021 Sep 28. PMID: 34681209
Article Published Date : Sep 27, 2021
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Rethinking therapeutic strategies for anorexia nervosa.Dec 31, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Neurosci. 2020 ;14:43. Epub 2020 Feb 4. PMID: 32116500
Article Published Date : Dec 31, 2019
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Anorexia
[+]

Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.Jan 14, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Neuroimage. 2020 10 15 ;220:117049. Epub 2020 Jun 30. PMID: 32619708
Article Published Date : Jan 14, 2020
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Additional Keywords : Altered States Of Consciousness
[+]

Simultaneous production of psilocybin and a cocktail of β-carboline monoamine oxidase inhibitors in 'magic' mushrooms.Nov 13, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Chemistry. 2019 Nov 14. Epub 2019 Nov 14. PMID: 31729089
Article Published Date : Nov 13, 2019
Study Type : In Vitro Study
Additional Links
Substances : Mushrooms: All , Psilocybin
Pharmacological Actions : Monoamine Oxidase Inhibitors
[+]

Spontaneous spiritual awakenings: phenomenology, altered states, individual differences, and well-being.Dec 31, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Psychol. 2021 ;12:720579. Epub 2021 Aug 19. PMID: 34489825
Article Published Date : Dec 31, 2020
Study Type : Review
Additional Links
Substances : Psilocybin
Additional Keywords : Altered States Of Consciousness, Spiritual Experiences
[+]

The current research shows potential for psilocybin as a treatment option for chronic pain relief.Aug 07, 2024

Pubmed Data : Reg Anesth Pain Med. 2024 Aug 8. Epub 2024 Aug 8. PMID: 39106989
Article Published Date : Aug 07, 2024
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Neuropathic Pain
Pharmacological Actions : Analgesics
[+]

The effects of hallucinogens on gene expression.Dec 31, 2017

Pubmed Data : Curr Top Behav Neurosci. 2018 ;36:137-158. PMID: 28677095
Article Published Date : Dec 31, 2017
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Anxiety, Depression
Additional Keywords : Gene Expression Regulation
[+]

The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression.Jun 05, 2024

Pubmed Data : J Clin Exp Neuropsychol. 2024 Jun 6:1-29. Epub 2024 Jun 6. PMID: 38842300
Article Published Date : Jun 05, 2024
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

The psilocybin-telomere hypothesis.Dec 31, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Med Hypotheses. 2020 Jan ;134:109406. Epub 2019 Sep 24. PMID: 31634774
Article Published Date : Dec 31, 2019
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Aging
Pharmacological Actions : Neurogenesis, Telomere Protective
Additional Keywords : Low-Dose Pharmacology
[+]

The role of psilocybin-assisted psychotherapy to support patients with cancer.Sep 05, 2021

Pubmed Data : J Holist Nurs. 2021 Sep 6:8980101211039086. Epub 2021 Sep 6. PMID: 34482761
Article Published Date : Sep 05, 2021
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Cancers: Psychological Stress
Pharmacological Actions : Anti-Anxiety Agents, Antidepressive Agents
[+]

The study suggested that the hot-water extracts of the four psilocybin-containing magic mushrooms have potential anti-inflammatory effects.Dec 31, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Inflamm Res. 2021 ;14:3729-3738. Epub 2021 Aug 5. PMID: 34385833
Article Published Date : Dec 31, 2020
Study Type : In Vitro Study
Additional Links
Substances : Psilocybin
Diseases : Inflammation
Pharmacological Actions : Anti-Inflammatory Agents, Cyclooxygenase 2 Inhibitors, Interleukin-1 beta downregulation, Interleukin-6 Downregulation, Tumor Necrosis Factor (TNF) Alpha Inhibitor
[+]

The therapeutic potential of microdosing psychedelics in depression Dec 31, 2019

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Ther Adv Psychopharmacol. 2020 ;10:2045125320950567. Epub 2020 Aug 27. PMID: 32922736
Article Published Date : Dec 31, 2019
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin, Psychedelics:All
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

The use of psilocybin for treatment-resistant depression.Aug 31, 2022

Pubmed Data : Laeknabladid. 2022 Sep ;108(9):403-410. PMID: 36040772
Article Published Date : Aug 31, 2022
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Therapeutic effect of psilocybin in addiction.Dec 31, 2022

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Psychiatry. 2023 ;14:1134454. Epub 2023 Feb 9. PMID: 36846225
Article Published Date : Dec 31, 2022
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Alcohol Addiction, Drug Addiction, Tobacco Addiction/Withdrawal
[+]

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.May 18, 2023

Pubmed Data : World J Psychiatry. 2023 May 19 ;13(5):182-190. Epub 2023 May 19. PMID: 37303932
Article Published Date : May 18, 2023
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Depression
Pharmacological Actions : Antidepressive Agents
[+]

Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.Aug 12, 2018

Pubmed Data : Int Rev Psychiatry. 2018 Aug 13:1-14. Epub 2018 Aug 13. PMID: 30102082
Article Published Date : Aug 12, 2018
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Cancers: All, Depression
[+]

This review will explore the potential of psilocybin in the treatment of neuropsychiatry-related conditions.May 14, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Molecules. 2021 May 15 ;26(10). Epub 2021 May 15. PMID: 34063505
Article Published Date : May 14, 2021
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Anxiety: End of Life, Cancers: All
Pharmacological Actions : Anti-Anxiety Agents
[+]

This reviews the pharmacology of psychedelic drugs and the therapeutic potentials of these fascinating compounds in mood disorders.Dec 31, 2017

Pubmed Data : Prog Brain Res. 2018 ;242:69-96. Epub 2018 Aug 31. PMID: 30471683
Article Published Date : Dec 31, 2017
Study Type : Review
Additional Links
Substances : Lysergic Acid Diethylamide (LSD), Psilocybin
Diseases : Depression, Mood Disorders
Pharmacological Actions : Antidepressive Agents
[+]

Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders.Dec 31, 2021

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Front Pharmacol. 2022 ;13:927984. Epub 2022 Jun 28. PMID: 35837277
Article Published Date : Dec 31, 2021
Study Type : Review
Additional Links
Substances : Psilocybin, Psychedelics:All
Diseases : Anxiety, Depression
[+]

What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.Dec 31, 2020

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Porto Biomed J. 2021 Jan-Feb;6(1):e128. Epub 2021 Feb 11. PMID: 33884324
Article Published Date : Dec 31, 2020
Study Type : Review
Additional Links
Substances : Psilocybin
Diseases : Depression, Obsessive-Compulsive Disorder, Substance Abuse
Pharmacological Actions : Antidepressive Agents

Copyright: xfotostudio / 123RF Stock Photo

Psilocybin Related Articles

Mushroom Medicine: Psilocybin Shows Promise for Anorexia Treatment
Written by GreenMedInfo Research Group
In a groundbreaking study, researchers have found that a single dose of psilocybin - the psychoactive compound in "magic mushrooms" - may offer a new ray of hope for individuals struggling with anorexia nervosa, a devastating eating disorder that has long stumped medical professionals.
Calm Anxiety Naturally: 7 Top Substances
Written by GreenMedInfo Research Group
In the face of the mounting costs of anxiety in the U.S. and globally, here are seven substances that act as natural anti-anxiety agents and may make a difference in addressing the unprecedented levels of stress people are facing today, in the wake of the COVID crisis.
7 Natural Options to Relieve Cluster Headaches
Written by GreenMedInfo Research Group
If you suffer from the intense pain of cluster headaches, you don’t have to reach for narcotic pain relievers. Try these seven natural options to relieve cluster headache pain without addictive medications
Beyond Psychiatry's Chemical Straight Jacket: Psilocybin's Paradigm-Shattering Success Healing Deep-Seated Depression
Written by GMI Reporter
Discover how psilocybin, the active compound in 'magic mushrooms,' is challenging conventional antidepressant therapies. Could this controversial substance hold the secret to healing deep-seated mental anguish?
Are Psilocybin Mushrooms a Game Changer for Severe Anxiety/Depression?
Written by Dr. Michael Murray
Two studies show why psilocybin, the active ingredient in “magic mushrooms,” is being hailed as a game changer for people with severe depression and anxiety
Have You Noticed? GreenMedInfo's Explosion of Cutting-Edge Natural Health Research in 2024
Written by GreenMedInfo Research Group
If you think all health news sounds the same, GreenMedInfo is turning that notion on its head in 2024 with an avalanche of pioneering natural medicine research
Magic Mushroom Ingredient May Improve Mental Health
Written by GreenMedInfo Research Group
Are you looking to support positive mental health without using pharmaceuticals? Psilocybin may be gaining mainstream acceptance by providing a safe "trip" out of desolation and into a more open, positive state of mind

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Connect with GreenMedInfo